Korean J healthc assoc Infect Control Prev.  2023 Dec;28(2):210-215. 10.14192/kjicp.2023.28.2.210.

The History, Domestic and International Epidemiology, and Prospects of Scabies that Need Attention

• Lee E
• Baek YJ
• Jung J
• Kim TH

• KMID: 2549948
• DOI: http://doi.org/10.14192/kjicp.2023.28.2.210

Abstract

Scabies is a skin infestation caused by Sarcoptes scabiei var. hominis. Scabies is a common condition that is found worldwide and which affects people of all races and social classes. Scabies is hyperendemic throughout the developing world, particularly in sub-Saharan Africa, India, the Aboriginal regions of northern Australia, and the South Pacific Islands. Scabies can spread easily under crowded conditions, where close body and skin contact is common. Institutions such as nursing homes, extended-care facilities, and prisons are often the sites of scabies outbreaks. Scabies can easily be passed on by an infested person to household members and sexual partners. Scabies is prevented by avoiding direct skin-to-skin contact with an infested person or items such as clothing or bedding used by an infested person. Treatment of scabies is usually recommended for members of the same household, particularly for those with prolonged skin-to-skin contact. All household members and other potentially exposed persons should be treated simultaneously with the infested person to prevent re-exposure and re-infestation. Improved access to personal hygiene and healthcare for all displaced, homeless, or institutionalized people should be implemented.

Keyword

Scabies; Infection control; Health personnel

Reference

1. Heukelbach J, Feldmeier H. 2006; Scabies. Lancet. 367:1767–74. DOI: 10.1016/S0140-6736(06)68772-2. PMID: 16731272.

2. Lee WK, Cho BK. 1995; Taxonomical approach to scabies mites of human and animals and their prevalence in Korea. Korean J Parasitol. 33:85–94. DOI: 10.3347/kjp.1995.33.2.85. PMID: 7551808.

3. Kim HS, Jung YJ, Kim SY, Kim JH, Nam HJ, Kim CK. 2008; An outbreak of scabies in neurosurgery-intensive care unit of a general hospital. Korean J Nosocomial Infect Control. 13:16–23.

4. Hicks MI, Elston DM. 2009; Scabies. Dermatol Ther. 22:279–92. DOI: 10.1111/j.1529-8019.2009.01243.x. PMID: 19580575.

5. Lane JE. 1928; Bonomo's letter to Redi: an important document in the history of scabies. Arch Derm Syphilol. 18:1–25. DOI: 10.1001/archderm.1928.02380130004001.

6. Ramos-e-Silva M. 1998; Giovan Cosimo Bonomo (1663-1696): discoverer of the etiology of scabies. Int J Dermatol. 37:625–30. DOI: 10.1046/j.1365-4362.1998.00400_1.x. PMID: 9732015.

7. Rasmussen JE. 1994; Scabies. Pediatr Rev. 15:110–4. quiz 114. DOI: 10.1542/pir.15-3-110. PMID: 7518921.

8. Mellanby K. 1941; Transmission of scabies. Br Med J. 2:405–6. DOI: 10.1136/bmj.2.4211.405. PMID: 20783868. PMCID: PMC2162942.

9. Karimkhani C, Colombara DV, Drucker AM, Norton SA, Hay R, Engelman D, et al. 2017; The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis. 17:1247–54. DOI: 10.1016/S1473-3099(17)30483-8. PMID: 28941561.

10. Hengge UR, Currie BJ, Jäger G, Lupi O, Schwartz RA. 2006; Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 6:769–79. DOI: 10.1016/S1473-3099(06)70654-5. PMID: 17123897.

11. Chosidow O. 2000; Scabies and pediculosis. Lancet. 355:819–26. DOI: 10.1016/S0140-6736(99)09458-1. PMID: 10711939.

12. Buehlmann M, Beltraminelli H, Strub C, Bircher A, Jordan X, Battegay M, et al. 2009; Scabies outbreak in an intensive care unit with 1,659 exposed individuals--key factors for controlling the outbreak. Infect Control Hosp Epidemiol. 30:354–60. DOI: 10.1086/596113. PMID: 19254159.

13. Chosidow O. 2006; Clinical practices. Scabies. N Engl J Med. 354:1718–27. DOI: 10.1056/NEJMcp052784. PMID: 16625010.

14. Mahé A, Faye O, N'Diaye HT, Ly F, Konaré H, Kéita S, et al. 2005; Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 99:39–47. DOI: 10.1016/j.trstmh.2004.03.008. PMID: 15550260.

15. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. 2005; Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 83:34–42.

16. Downs AM, Harvey I, Kennedy CT. 1999; The epidemiology of head lice and scabies in the UK. Epidemiol Infect. 122:471–7. DOI: 10.1017/S0950268899002277. PMID: 10459652. PMCID: PMC2809643.

17. Blas M, Bravo F, Castillo W, Castillo WJ, Ballona R, Navarro P, et al. 2005; Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection. Am J Trop Med Hyg. 72:855–7. DOI: 10.4269/ajtmh.2005.72.855. PMID: 15964976.

18. del Giudice P, Sainte Marie D, Gérard Y, Couppié P, Pradinaud R. 1997; Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients? J Infect Dis. 176:1090–2. DOI: 10.1086/516518. PMID: 9333174.

19. Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS. 2023; Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: part 1. Epidemiology, clinical manifestations, and diagnosis. Korean J Dermatol. 61:393–403.

20. Kim JH, Cheong HK. 2019; Epidemiologic trends and seasonality of scabies in South Korea, 2010-2017. Korean J Parasitol. 57:399–404. DOI: 10.3347/kjp.2019.57.4.399. PMID: 31533406. PMCID: PMC6753298.

21. Kim SJ, Jeong JS, Park ES, Choi SH. 2019; A survey on the scabies outbreak and infection control. Korean J healthc assoc Infect Control Prev. 24:1–10. DOI: 10.14192/kjhaicp.2019.24.1.1.

22. Kim JH, Jeong YS, Lee EJ, Kim TH. 2009; An experience in successful infection control against Norwegian scabies in hospital and a proposal for hospital infection control. Korean J Nosocomial Infect Control. 14:36–42.

23. Lee E, Park SY, Lee E, Kim TH. 2021; previous long-term care facility admission as a risk factor for scabies in a medical facility. J Korean Med Sci. 36:e337. DOI: 10.3346/jkms.2021.36.e337. PMID: 34931498. PMCID: PMC8688348.

24. Jang IY, Lee HY, Lee E. 50th Anniversary Committee of Korean Geriatrics Society. 2019; Geriatrics fact sheet in Korea 2018 from national statistics. Ann Geriatr Med Res. 23:50–3. DOI: 10.4235/agmr.19.0013. PMID: 32743288. PMCID: PMC7387592.

25. Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. 2017; European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 31:1248–53. DOI: 10.1111/jdv.14351. PMID: 28639722.

26. Park J, Park SY, Han J, Lee SY, Kim GE, Jeong YS, et al. 2019; Identifying the time to cure for patients with classic scabies after infection control intervention in acute care hospital settings. Am J Infect Control. 47:588–90. DOI: 10.1016/j.ajic.2018.10.007. PMID: 30527284.

27. Chhaiya SB, Patel VJ, Dave JN, Mehta DS, Shah HA. 2012; Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J Dermatol Venereol Leprol. 78:605–10. DOI: 10.4103/0378-6323.100571. PMID: 22960817.

28. Meyersburg D, Kaiser A, Bauer JW. 2022; 'Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study'. J Dermatolog Treat. 33:774–7. DOI: 10.1080/09546634.2020.1774489. PMID: 32495666.

29. Nishizawa T, Ishikawa K, Takamizawa M, Arioka H. 2022; Successful treatment of refractory crusted scabies. BMJ Case Rep. 15:e251842. DOI: 10.1136/bcr-2022-251842. PMID: 36357115.

30. Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF. 2008; Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol. 3:57–66. DOI: 10.2217/17460913.3.1.57. PMID: 18230034.

31. Thomas J, Carson CF, Peterson GM, Walton SF, Hammer KA, Naunton M, et al. 2016; Therapeutic potential of tea tree oil for scabies. Am J Trop Med Hyg. 94:258–66. DOI: 10.4269/ajtmh.14-0515. PMID: 26787146. PMCID: PMC4751955.

32. Korea Centers for Disease Control. 2019. Guide for prevention and management of scabies in convalescent hospital. Korea Centers for Disease Control and Prevention;Cheongju: p. 1–28.

33. Park SY, Roh JY, Lee JY, Kim DW, Yoon TJ, Sim WY, et al. 2014; A clinical and epidemiological study of scabies in Korea: a multicenter prospective study. Korean J Dermatol. 52:457–64.

34. Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS. 2023; Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: part 2. Treatment and prevention. Korean J Dermatol. 61:463–71.